Frequency and risk factors of infectious complications in neutropenic patients infected with HIV

被引:17
作者
Meynard, JL [1 ]
Guiguet, M [1 ]
Arsac, S [1 ]
Frottier, J [1 ]
Meyohas, MC [1 ]
机构
[1] HOP ST ANTOINE,INSERM,U263,F-75571 PARIS,FRANCE
关键词
AIDS; neutropenia; bacterial infections;
D O I
10.1097/00002030-199708000-00007
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To determine causes, incidence and factors associated with infections in neutropenic [polymorphonuclear neutrophil (PMN) < 1000 x 10(6)/l] HIV-infected patients. Design: Prospective study. Setting: Infectious disease service of a 1000-bed university teaching hospital in Paris, France. Patients: HIV-infected patients with a PMN count of < 1000 x 10(6)/l confirmed on two occasions were included in the study. Baseline characteristics, cause of neutropenia and occurrence of infectious episodes were analysed. Results: The cause of neutropenia was lymphoma in four cases (6.5%), antineoplastic chemotherapy in seven (11.3%), zidovudine in 32 (51%), trimethoprim-sulphamethoxazole (TMP-SMX) in 28 (45%) and ganciclovir in 11 (18%). Fifteen patients (24%) developed infectious complications. Neutropenia induced by chemotherapy or lymphoma was more frequently complicated by infectious episodes (P = 0.02). Neutropenia in the previous 3 months (P = 0.05), presence of a central venous catheter (P = 0.05) and a trough PMN count (P = 0.02) were the three risk factors of infection retained in a logistic model. Conclusion: Neutropenia induced by zidovudine, gangiclovir or TMP-SMX, are less complicated by infectious episodes than neutropenia induced by antineoplastic chemotherapy. Overall, infectious episodes in neutropenic HIV-infected patients appear lower than in patients with haemobiologic malignancies.
引用
收藏
页码:995 / 998
页数:4
相关论文
共 16 条
  • [1] HEMATOLOGIC MANIFESTATIONS IN HOMOSEXUAL MEN WITH KAPOSIS SARCOMA
    ABRAMS, DI
    CHINN, EK
    LEWIS, BJ
    VOLBERDING, PA
    CONANT, MA
    TOWNSEND, RM
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1984, 81 (01) : 13 - 18
  • [2] CASTELLA A, 1984, AM J CLIN PATHOL, V84, P425
  • [3] CLEMENT M, 1989, OPPORTUNISTIC INFECT, P88
  • [4] FARBER BF, 1991, INFECT CONT HOSP EP, V12, P429, DOI 10.1086/646373
  • [5] FOLKS TM, 1991, BLOOD, V77, P1625
  • [6] GROOPMAN JE, 1990, REV INFECT DIS, V12, P931
  • [7] OUTCOME FOR HOSPITALIZED-PATIENTS WITH FEVER AND NEUTROPENIA WHO ARE INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS
    HAMBLETON, J
    ARAGON, T
    MODIN, G
    NORTHFELT, DW
    SANDE, MA
    [J]. CLINICAL INFECTIOUS DISEASES, 1995, 20 (02) : 363 - 371
  • [8] Hermans P, 1995, AIDS, V9, pS9
  • [9] HERMANS P, 1995, 35 INT C ANT AG CHEM
  • [10] GUIDELINES FOR THE USE OF ANTIMICROBIAL AGENTS IN NEUTROPENIC PATIENTS WITH UNEXPLAINED FEVER
    HUGHES, WT
    ARMSTRONG, D
    BODEY, GP
    FELD, R
    MANDELL, GL
    MEYERS, JD
    PIZZO, PA
    SCHIMPFF, SC
    SHENEP, JL
    WADE, JC
    YOUNG, LS
    YOW, MD
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1990, 161 (03) : 381 - 396